MYX mayne pharma group limited

"We'd hope MYX with Nextstellis is different - we are just...

  1. 336 Posts.
    lightbulb Created with Sketch. 271
    "We'd hope MYX with Nextstellis is different - we are just talking about "cycles". Regardless of which way they are reported - the growth rates are similar and unfortunately the last few months have been flat. Reporting type is semantics as the market is wanting revenue growth for a product that has cost Hundreds and Hundreds and Hundreds of $millions."

    The definition of semantics is "meaning the same thing", clearly IQVIA cycles (as presented in May) are 23% lower on average than demand cycles (as presented in Feb), so not the same thing and not semantics. I am sure Mithra would not have been happy to be paid licence fees based on IQVIA cycles which are 23% lower. So cycles ain't cycles.
    As far as cycles growth rates, this year's growth average is 4.6%, not great but not flat and I agree that the market wants to see revenue growth but no figures have been made available but I am sure that if demand cycles had been presented instead of IQVIA cycles, the market might be factoring in revenue growth of a different kind.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.25
Change
-0.150(2.78%)
Mkt cap ! $426.5M
Open High Low Value Volume
$5.35 $5.41 $5.19 $1.239M 231.7K

Buyers (Bids)

No. Vol. Price($)
1 1000 $5.17
 

Sellers (Offers)

Price($) Vol. No.
$5.36 1000 1
View Market Depth
Last trade - 16.11pm 25/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.